120 related articles for article (PubMed ID: 17111385)
1. The apoptosis of blood polymorphonuclear leukocytes in sickle cell disease.
Ozdogu H; Boga C; Sozer O; Sezgin N; Kizilkilic E; Maytalman E; Yalcintas D
Cytometry B Clin Cytom; 2007 Jul; 72(4):276-80. PubMed ID: 17111385
[TBL] [Abstract][Full Text] [Related]
2. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants.
Amer J; Ghoti H; Rachmilewitz E; Koren A; Levin C; Fibach E
Br J Haematol; 2006 Jan; 132(1):108-13. PubMed ID: 16371026
[TBL] [Abstract][Full Text] [Related]
3. Modulation of redox pathways in neutrophils from sickle cell disease patients.
Aslan M; Canatan D
Exp Hematol; 2008 Nov; 36(11):1535-44. PubMed ID: 18809239
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory potential of neutrophils detected in sickle cell disease.
Lum AF; Wun T; Staunton D; Simon SI
Am J Hematol; 2004 Jun; 76(2):126-33. PubMed ID: 15164377
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 suppresses polymorphonuclear neutrophil apoptosis after acute lung injury.
Jinzhou Z; Tao H; Wensheng C; Wen W; Jincheng L; Qin C; Hailong Z; Weiyong L; Dinghua Y
J Trauma; 2008 Apr; 64(4):1055-60. PubMed ID: 18404075
[TBL] [Abstract][Full Text] [Related]
6. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression.
Szuster-Ciesielska A; Słotwińska M; Stachura A; Marmurowska-Michałowska H; Dubas-Slemp H; Bojarska-Junak A; Kandefer-Szerszeń M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):686-94. PubMed ID: 18083280
[TBL] [Abstract][Full Text] [Related]
7. Decreased exhaled nitric oxide in sickle cell disease: relationship with chronic lung involvement.
Girgis RE; Qureshi MA; Abrams J; Swerdlow P
Am J Hematol; 2003 Mar; 72(3):177-84. PubMed ID: 12605389
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of NADPH oxidase components and increased production of interferon-gamma by leukocytes from sickle cell disease patients.
Marçal LE; Dias-da-Motta PM; Rehder J; Mamoni RL; Blotta MH; Whitney CB; Newburger PE; Costa FF; Saad ST; Condino-Neto A
Am J Hematol; 2008 Jan; 83(1):41-5. PubMed ID: 17654682
[TBL] [Abstract][Full Text] [Related]
9. Alterations in cell maturity and serum survival factors may modulate neutrophil numbers in sickle cell disease.
Almeida CB; Favero ME; Pereira-Cunha FG; Lorand-Metze I; Saad ST; Costa FF; Conran N
Exp Biol Med (Maywood); 2011 Nov; 236(11):1239-46. PubMed ID: 21998130
[TBL] [Abstract][Full Text] [Related]
10. Normal sublingual microcirculation during painful crisis in sickle cell disease.
van Beers EJ; Goedhart PT; Unger M; Biemond BJ; Ince C
Microvasc Res; 2008 May; 76(1):57-60. PubMed ID: 18423765
[TBL] [Abstract][Full Text] [Related]
11. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.
Ataga KI; Moore CG; Hillery CA; Jones S; Whinna HC; Strayhorn D; Sohier C; Hinderliter A; Parise LV; Orringer EP
Haematologica; 2008 Jan; 93(1):20-6. PubMed ID: 18166781
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide overproduction derived from inducible nitric oxide synthase increases cardiomyocyte apoptosis in human atrial fibrillation.
Han W; Fu S; Wei N; Xie B; Li W; Yang S; Li Y; Liang Z; Huo H
Int J Cardiol; 2008 Nov; 130(2):165-73. PubMed ID: 18585800
[TBL] [Abstract][Full Text] [Related]
13. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis.
van Tits LJ; van Heerde WL; Landburg PP; Boderie MJ; Muskiet FA; Jacobs N; Duits AJ; Schnog JB
Biochem Biophys Res Commun; 2009 Dec; 390(1):161-4. PubMed ID: 19799864
[TBL] [Abstract][Full Text] [Related]
14. A phase I/II study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis at the time of study.
Gonzalez P; Hackney AC; Jones S; Strayhorn D; Hoffman EB; Hughes G; Jacobs EE; Orringer EP
J Investig Med; 1997 Jun; 45(5):258-64. PubMed ID: 9249998
[TBL] [Abstract][Full Text] [Related]
15. Plasma protein C levels in children with sickle cell disease.
Karayalcin G; Lanzkowsky P
Am J Pediatr Hematol Oncol; 1989; 11(3):320-3. PubMed ID: 2782560
[TBL] [Abstract][Full Text] [Related]
16. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
Lanaro C; Franco-Penteado CF; Albuqueque DM; Saad ST; Conran N; Costa FF
J Leukoc Biol; 2009 Feb; 85(2):235-42. PubMed ID: 19004988
[TBL] [Abstract][Full Text] [Related]
17. The onset time of atracurium is prolonged in patients with sickle cell disease.
Dulvadestin P; Gilton A; Hernigou P; Marty J
Anesth Analg; 2008 Jul; 107(1):113-6. PubMed ID: 18635475
[TBL] [Abstract][Full Text] [Related]
18. Glomerular function in sickle cell disease patients during crisis.
Aderibigbe A; Arije A; Akinkugbe OO
Afr J Med Med Sci; 1994 Jun; 23(2):153-60. PubMed ID: 7625304
[TBL] [Abstract][Full Text] [Related]
19. High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophils.
Almeida CB; Traina F; Lanaro C; Canalli AA; Saad ST; Costa FF; Conran N
Br J Haematol; 2008 Sep; 142(5):836-44. PubMed ID: 18564357
[TBL] [Abstract][Full Text] [Related]
20. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients.
Bao B; Prasad AS; Beck FW; Snell D; Suneja A; Sarkar FH; Doshi N; Fitzgerald JT; Swerdlow P
Transl Res; 2008 Aug; 152(2):67-80. PubMed ID: 18674741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
